BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 12892035)

  • 1. Aspirin and cyclooxygenase-2 inhibitors.
    Armstrong TA
    Am J Health Syst Pharm; 2003 Jul; 60(14):1481. PubMed ID: 12892035
    [No Abstract]   [Full Text] [Related]  

  • 2. Variable platelet response to aspirin and clopidogrel in atherothrombotic disease.
    Maree AO; Fitzgerald DJ
    Circulation; 2007 Apr; 115(16):2196-207. PubMed ID: 17452618
    [No Abstract]   [Full Text] [Related]  

  • 3. [A 100 years of aspirin: a drug with a future?].
    Sánchez García P
    An R Acad Nac Med (Madr); 1997; 114(1):157-63; discussion 164-7. PubMed ID: 9324911
    [No Abstract]   [Full Text] [Related]  

  • 4. What price pain relief?
    Hochman JS; Shah NR
    Circulation; 2006 Jun; 113(25):2868-70. PubMed ID: 16785335
    [No Abstract]   [Full Text] [Related]  

  • 5. High on treatment platelet reactivity against aspirin by non-steroidal anti-inflammatory drugs--pharmacological mechanisms and clinical relevance.
    Hohlfeld T; Saxena A; Schrör K
    Thromb Haemost; 2013 May; 109(5):825-33. PubMed ID: 23238666
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aspirin and its rivals. As your options increase, your choices get harder.
    Harv Mens Health Watch; 2002 Dec; 7(5):1-5. PubMed ID: 12499131
    [No Abstract]   [Full Text] [Related]  

  • 7. [Pharmacology of aspirin].
    Tanasescu S; Lévesque H; Thuillez C
    Rev Med Interne; 2000 Mar; 21 Suppl 1():18s-26s. PubMed ID: 10763201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rational use of analgesic and antiinflammatory drugs.
    Crofford LJ
    N Engl J Med; 2001 Dec; 345(25):1844-6. PubMed ID: 11752364
    [No Abstract]   [Full Text] [Related]  

  • 9. Impact of aspirin on the gastrointestinal-sparing effects of cyclooxygenase-2 inhibitors.
    Nathan JP; Castellanos JT; Rosenberg JM; Cicero LA
    Am J Health Syst Pharm; 2003 Feb; 60(4):392-4. PubMed ID: 12625225
    [No Abstract]   [Full Text] [Related]  

  • 10. Aspirin: new cardiovascular uses for an old drug.
    Patrono C
    Am J Med; 2001 Jan; 110(1A):62S-65S. PubMed ID: 11166001
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aspirin, NSAIDs, and cardiovascular risk: is there a link?
    Kapoor JR
    Am J Med; 2008 Nov; 121(11):e9. PubMed ID: 18954833
    [No Abstract]   [Full Text] [Related]  

  • 12. Doubt and certainty about nonsteroidal anti-inflammatory drugs in the year 2000: a multidisciplinary expert statement.
    Hawkey CJ; Lanas AI;
    Am J Med; 2001 Jan; 110(1A):79S-100S. PubMed ID: 11166005
    [No Abstract]   [Full Text] [Related]  

  • 13. Efficacy and safety of aspirin in the long-term management of atherothrombosis.
    Patrono C
    Haematologica; 2002 Jan; 87(1):6-8. PubMed ID: 11801459
    [No Abstract]   [Full Text] [Related]  

  • 14. Cardiovascular events and COX-2 inhibitors.
    Singh G
    JAMA; 2001 Dec; 286(22):2810-1; author reply 2811-2. PubMed ID: 11735748
    [No Abstract]   [Full Text] [Related]  

  • 15. Cardioprotective effects of aspirin compromised by other NSAIDs.
    Gottlieb S
    BMJ; 2003 Sep; 327(7414):520. PubMed ID: 12958094
    [No Abstract]   [Full Text] [Related]  

  • 16. [Are the NSAIDs able to compromising the cardio-preventive efficacy of aspirin?].
    Flipo RM
    Presse Med; 2006 Sep; 35(9 Spec No 1):1S53-60. PubMed ID: 17078596
    [TBL] [Abstract][Full Text] [Related]  

  • 17. COX-2 selective NSAIDs.
    Ryan NS
    Cleve Clin J Med; 2000 Jan; 67(1):67. PubMed ID: 10645679
    [No Abstract]   [Full Text] [Related]  

  • 18. [Does dual antiplatelet therapy always require gastroprotection? Gastroprotection with proton pump inhibitors is advisable for all patients who need dual antiplatelet therapy].
    Morini S; Zullo A
    G Ital Cardiol (Rome); 2010 Jun; 11(6):488-92; discussion 492. PubMed ID: 20922875
    [No Abstract]   [Full Text] [Related]  

  • 19. The coxibs, selective inhibitors of cyclooxygenase-2.
    Rich SA
    N Engl J Med; 2001 Dec; 345(23):1709. PubMed ID: 11759657
    [No Abstract]   [Full Text] [Related]  

  • 20. Controversies in COX-2 selective inhibition.
    Simon LS; Smolen JS; Abramson SB; Appel G; Bombardier C; Brater DC; Breedveld FC; Brune K; Burmester GR; Crofford LJ; Dougados M; DuBois RN; Fitzgerald GA; Frishman W; García Rodríguez LA; Hochberg MC; Kalden JR; Laine L; Langman MJ; Prescott SM; van de Putte LB; Whelton A; White WB; Willaims GH
    J Rheumatol; 2002 Jul; 29(7):1501-10. PubMed ID: 12136912
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.